Evid Invest
Who owns HCWBWhat HCWB owns — n/a

Who owns HCW Biologics Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of HCWB from SEC Form 13F filings across 12 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-06-30 reporting period, 12 institutions disclosed 103,505 shares of HCW Biologics Inc. worth $448,733 — about 7.8% of shares outstanding; the largest disclosed holder is JANE STREET GROUP, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

12

13F holders

$448,733

value, 2026 filers

7.8%

of shares outstanding (103,505 sh)

12

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of HCWB's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1JANE STREET GROUP, LLCNEW52,138$260,1680.0%3.9%new
2CITADEL ADVISORS LLCNEW19,942$99,5110.0%1.5%new
3HRT FINANCIAL LPNEW13,583$670.0%1%new
4VANGUARD FIDUCIARY TRUST CONEW6,510$32,4850.0%0.5%new
5Tower Research Capital LLC (TRC)NEW4,117$20,5440.0%0.3%new
6Connective Capital Management, LLCNEW3,338$16,6570.0%0.3%new
7VANGUARD CAPITAL MANAGEMENT LLCNEW2,003$9,9950.0%0.2%new
8Golden State Wealth Management, LLCNEW1,667$8,3180.0%0.1%new
9BARCLAYS PLCNEW191$9530.0%0%new
10Caitong International Asset Management Co., LtdNEW11$100.0%0%new
11OSAIC HOLDINGS, INC.NEW4$200.0%0%new
12UBS Group AGNEW1$50.0%0%new

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.